Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial

Autor: Kunkel, Joakim Bo¹ (AUTHOR), Holle, Sarah Louise Duus¹ (AUTHOR), Hassager, Christian^1,2 (AUTHOR), Pecini, Redi¹ (AUTHOR), Wiberg, Sebastian^1,2,3 (AUTHOR), Palm, Pernille¹ (AUTHOR), Holmvang, Lene¹ (AUTHOR), Bang, Lia Evi¹ (AUTHOR), Kjærgaard, Jesper¹ (AUTHOR), Thomsen, Jakob Hartvig⁴ (AUTHOR), Engstrøm, Thomas^1,3 (AUTHOR), Møller, Jacob Eifer^1,5 (AUTHOR), Lønborg, Jacob Thomsen¹ (AUTHOR), Frydland, Martin¹ (AUTHOR), Søholm, Helle^1,6 (AUTHOR) helle.soeholm@regionh.dk

Publikováno v: Trials. 11/5/2024, Vol. 25 Issue 1, p1-12. 12p.